
INO Valuation
Inovio Pharmaceuticals Inc
- Overview
- Forecast
- Valuation
- Earnings
INO Relative Valuation
INO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, INO is overvalued; if below, it's undervalued.
Historical Valuation
Inovio Pharmaceuticals Inc (INO) is now in the Fair zone, suggesting that its current forward PS ratio of 3179.87 is considered Fairly compared with the five-year average of -4.46. The fair price of Inovio Pharmaceuticals Inc (INO) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:1.47
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
1.05
P/B
Median3y
1.45
Median5y
2.53
-133.47
FCF Yield
Median3y
-94.72
Median5y
-63.87
Competitors Valuation Multiple
The average P/S ratio for INO's competitors is 515.29, providing a benchmark for relative valuation. Inovio Pharmaceuticals Inc Corp (INO) exhibits a P/S ratio of 3077.95, which is 497.32% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch

AIRE
reAlpha Tech Corp
0.419
USD
-7.51%

ACET
Adicet Bio Inc
0.771
USD
-0.52%

SGA
Saga Communications Inc
13.550
USD
+0.97%

AVTE
Aerovate Therapeutics Inc
0
USD
0.00%

PEPG
PepGen Inc
1.450
USD
+0.69%

ASYS
Amtech Systems Inc
4.680
USD
-0.43%

PRTS
Carparts.Com Inc
0.860
USD
+6.05%

DGHI
Digihost Technology Inc
0
USD
+6.82%

ELTK
Eltek Ltd
10.464
USD
+0.62%

ARMP
Armata Pharmaceuticals Inc
2.390
USD
-3.82%
FAQ

Is Inovio Pharmaceuticals Inc (INO) currently overvalued or undervalued?
Inovio Pharmaceuticals Inc (INO) is now in the Fair zone, suggesting that its current forward PS ratio of 3179.87 is considered Fairly compared with the five-year average of -4.46. The fair price of Inovio Pharmaceuticals Inc (INO) is between to according to relative valuation methord.

What is Inovio Pharmaceuticals Inc (INO) fair value?

How does INO's valuation metrics compare to the industry average?

What is the current P/B ratio for Inovio Pharmaceuticals Inc (INO) as of Jul 27 2025?

What is the current FCF Yield for Inovio Pharmaceuticals Inc (INO) as of Jul 27 2025?

What is the current Forward P/E ratio for Inovio Pharmaceuticals Inc (INO) as of Jul 27 2025?
